£10bn NHS medtech spend undermined by ‘lack of data’, warns DHSC director

david-lawson

The lack of information about the performance and value for money of medtech products is leading to ineffective procurement and wasting scarce NHS funding, a senior government official has told HSJ.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here